Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 98,373 $ 92,708
Short-term restricted cash 10 349
Accounts receivable, net 44,796 50,411
Inventory 31,088 31,510
Prepaid expenses and other current assets 6,342 6,792
Total current assets 180,609 181,770
Long-term restricted cash 57 60
Property and equipment, net 15,751 16,613
Leased right-of-use assets 9,864 10,978
Intangible assets, net 173,570 187,971
Goodwill 238,330 238,330
Deferred tax assets 73,492 67,284
Other long-term assets 1,752 2,785
Total assets 693,425 705,791
Current liabilities:    
Accounts payable 13,597 13,442
Accrued price protection liability 8,024 12,557
Accrued expenses and other current liabilities 30,661 31,171
Accrued compensation 10,146 9,392
Total current liabilities 62,428 66,562
Long-term lease liabilities 8,029 9,335
Long-term debt 207,197 206,909
Other long-term liabilities 7,614 8,065
Total liabilities 285,268 290,871
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 72,345 shares issued and outstanding at March 31, 2020 and 71,931 shares issued and outstanding December 31, 2019 7 7
Additional paid-in capital 539,035 529,596
Accumulated other comprehensive loss (1,620) (887)
Accumulated deficit (129,265) (113,796)
Total stockholders’ equity 408,157 414,920
Total liabilities and stockholders’ equity $ 693,425 $ 705,791